CTRI/2019/07/020268招募中4 期
A single-center, open-labelled, investigator-initiated study to evaluate the safety and effectiveness of an appetite stimulating tonic containing multi-vitamins, lysine and zinc in patients with loss of appetite.
Dr Nagaraj S0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1.Adult male or female patients aged 18 to 55 years of age.
- •2.Patients with a history of loss of appetite and a CNAQ appetite score of <28 due to acute or chronic illness.
- •3.Participants should have the ability to understand the requirements of the study.
- •4.Participants willing to abide by the study restrictions and return for the required assessments.
- •5.Participants willing to sign informed consent document.
排除标准
- •1.Patients less than 18 years or older than 55 years of age.
- •2.Pregnant and lactating women
- •3.Patients with or currently taking any antihistaminic or ayurvedic tonics for appetite loss during and 7 days before the study.
- •4.Patients with known history of hypersensitivity to the study drug used for therapy of appetite loss
- •5.Patients with a known condition that may interfere with the study drugâ??s absorption or metabolism at physicianâ??s discretion.
研究者
相似试验
招募中
不适用
A Single-Center, Single-arm, Open-label, Exploratory Study to Evaluate the Efficacy and Safety of Intradermal Injection of Hyaluronic Acid FillerKCT0007664Hugel20
招募中
不适用
A prospective, single-center, open-Label, investigator initiated trial to compare the efficacy and safety of non-contact tonometer(HNT-1/P) and goldmann applanation tonometer for intraocular pressure measurementsKCT0002549Asan Medical Center84
招募中
3 期
Whether cooling the scalp during chemotherapy can reduce hairfall in patients with cancerCTRI/2023/05/053011JIPMER
已完成
1 期
Reducing symptoms in acute Acute Heart Failure with a man made vessel dilator peptideAcute Decompensated Congestive Heart Failure (ADCHF)Cardiovascular - Other cardiovascular diseasesRespiratory - Other respiratory disorders / diseasesACTRN12609000998246Madeleine Pharmaceuticals36
进行中（未招募）
1 期
A pilot study to assess the efficacy and safety of OBE2109 in subjects with rectovaginal endometriosis.EUCTR2017-004043-21-FRObsEva SA9